Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gerhartz

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Leukemia & Lymphoma|June 1, 1994
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's diseaseR Fuchs, M Löffler, M Pfreundschuh, et al.
Blood|May 15, 1989
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantationE Holler, H J Kolb, E Hiller, et al.
Leukemia|January 1, 1994
A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative GroupH H Gerhartz, R Marcus, A Delmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSFM Engelhard, H Gerhartz, G Brittinger, et al.
Cancer Investigation|January 1, 1996
Interleukin-3 plus low-dose cytosine arabinoside for advanced myelodysplasia: a pilot study. EORTC Leukemia GroupH H Gerhartz, H H Zwierzina, J Walther, et al.
Blut|March 1, 1988
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapyH H Gerhartz, E Thiel, G Brittinger, et al.
Annals of Hematology|April 1, 1992
A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia. EORTC Leukemia Cooperative GroupR Willemze, N van der Lely, H Zwierzina, et al.
Bone Marrow Transplantation|January 1, 1989
Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuriaH J Kolb, E Holler, C Bender-Götze, et al.
Onkologie|June 1, 1984
[Cytostatic therapy of advanced squamous cell carcinoma of the head and neck. A randomized study comparing cis-dichlorodiammineplatinum(II) and bleomycin with methotrexate and vindesine]H W von Heyden, M Schröder, A Scherpe, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1985
Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesineH W von Heyden, M Schröder, A Scherpe, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|June 1, 1994
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's diseaseR Fuchs, M Löffler, M Pfreundschuh, et al.
Blood|May 15, 1989
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantationE Holler, H J Kolb, E Hiller, et al.
Leukemia|January 1, 1994
A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative GroupH H Gerhartz, R Marcus, A Delmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSFM Engelhard, H Gerhartz, G Brittinger, et al.
Cancer Investigation|January 1, 1996
Interleukin-3 plus low-dose cytosine arabinoside for advanced myelodysplasia: a pilot study. EORTC Leukemia GroupH H Gerhartz, H H Zwierzina, J Walther, et al.
Blut|March 1, 1988
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapyH H Gerhartz, E Thiel, G Brittinger, et al.
Annals of Hematology|April 1, 1992
A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia. EORTC Leukemia Cooperative GroupR Willemze, N van der Lely, H Zwierzina, et al.
Bone Marrow Transplantation|January 1, 1989
Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuriaH J Kolb, E Holler, C Bender-Götze, et al.
Onkologie|June 1, 1984
[Cytostatic therapy of advanced squamous cell carcinoma of the head and neck. A randomized study comparing cis-dichlorodiammineplatinum(II) and bleomycin with methotrexate and vindesine]H W von Heyden, M Schröder, A Scherpe, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1985
Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesineH W von Heyden, M Schröder, A Scherpe, et al.
Pageof 12